Mr. Director (Non-Gazetted) Medical and Health Services Raj, Jaipur's letter Araj/UTB/2023/369 dated 24.07.2023 and letter number 392 dated 04.08.2023 against the clear vacant posts of nursing personnel and paramedical staff in the district dated 31.03. 2024 or until regular personnel are available on vacant posts, whichever is earlier.

Post : Pharmacist

Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India invites applications from Indian Nationals for the appointment of the following position.

Post : SRF, JRF

Emcure is fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally. With a presence in over 70 countries, Emcure's goal is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

Piramal Group has interests in a portfolio of businesses including financial services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited), and real estate (Piramal Realty). With operations in 30 countries and brand presence in over 100 markets, the Group’s turnover is ~1.9 billion usd in FY 2022. Driven by its core values, the Group pursues inclusive growth, while adhering to ethical and value-driven practices.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Inviting candidates for a walk in interview for Formulations Manufacturing plant (SEZ- I, Matoda) Ahmedabad

Sun Pharma is the fourth largest generic pharmaceutical company in the world It is also India's largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high quality medicines trusted by customers and patients in over ISO countries and has multiple manufacturing facilities and R&D centers. Our leadership is approachable, recognizes people's passions for growth, gives them a voice and empowers them to make a positive change.

CORONA Remedies Pvt. Ltd.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today. Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.

Pfizer is the world's premier biopharmaceutical company taking new approaches to better health.  We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

Hon’ble Shri Kalraj Mishra, Governor, Rajasthan presented the ET Leadership Excellence Award 2023 for significant contribution in the field of Health Management to Dr. P.R. Sodani, President of IIHMR University, Jaipur. Dr. P.R. Sodani has been a well-known Health Economist and Public Health Professor for more than two decades and has mentored faculty, students, and research scholars. He has made significant contributions through research in strengthening the Health Systems of Rajasthan.

The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, was apprised of a Memorandum of Understanding (MoU) signed on 4th June, 2023 between the Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare, Government of the Republic of India and Ministry of Health, Government of the Republic of Suriname on cooperation in the field of Medical Product Regulation. This was signed during the visit of the President of India to Suriname.

Government to open 25000 Jan Aushadhi Kendras to make medicines available at affordable prices. Prime Minister Shri Narendra Modi during his Independence Day speech at Red Fort said that the government has plans to increase the number of 'Jan Aushadhi Kendras' from 10,000 to 25,000.

Rajkot Municipal Corporation (RMC) is a local government committed to provide basic infrastructure facilities including entertainment facilities to the people of the city. RMC is very well known for the managing the city by using private sector participation as well as introduction of innovative mechanism in management to serve people efficiently. City has prepared different plans for improving services and to nullify gap between services and demands.

Post : Pharmacist

GOVERNMENT OF MAHARASHTRA GENERAL ADMINISTRATION DEPARTMENT GOVERNMENT DECISION NO. 136/Ka-13 No dated 21 November 2022 Government of Maharashtra, General Administration Department Government Decision no. BCC 2018/Pro.No.427/16-B, dt. 10 May 2023, Government of Maharashtra, Rural Development Department Government Circular No. Miscellaneous 2022/ P.No. 11/Aastha-8, dt.

Rusoma Laboratories Private Limited, is committed to producing high quality, lifesaving & effective pharmaceutical products that patients & consumers can depend on. To meet this commitment we dedicate ourselves to the creation of a safe & quality-focused production environment As the pioneers in Large Volume Parenteral (LVP) production, we ensure that all our procedures & processes are enforced with consumer safety at the centre & in compliance with the applicable rules, regulations & standards.

HLL Lifecare Limited, a Schedule B, Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare is India’s leading manufacturers and marketers of Contraceptives, Healthcare and Pharma products & services.

Rusoma Laboratories Private Limited, is committed to producing high quality, lifesaving & effective pharmaceutical products that patients & consumers can depend on. To meet this commitment we dedicate ourselves to the creation of a safe & quality-focused production environment As the pioneers in Large Volume Parenteral (LVP) production, we ensure that all our procedures & processes are enforced with consumer safety at the centre & in compliance with the applicable rules, regulations & standards.

Government of Maharashtra Rural Development Department. Government Decision No. Miscellaneous-2022/P.No.11/Aastha-8 Dated 15 November 2022, Government of Maharashtra General Administration Department Government Decision No. Pranim 1222/P.No. 136/Ka-13B dated 21 November 2022, Government of Maharashtra, General Administration Department Government Decision no. BCC 2018/Pro.No.427/16-B, dt. 10th May, 2023, Government of Maharashtra, Rural Development Department Government Circular No. Miscellaneous 2022/P.No.11/Aastha-8, dt.

Order No. 14 (1) Chiswa/2/2023/Rajkaj-940/Part-4 dated 13.07.2023, Director (Araj), Medical and Health Services, Rajasthan, Jaipur's letter number Araj/UTB/2023/369 dated 24.07.2023 and Director (Araj), Medical and Health Services, Rajasthan, Jaipur's letter number Araj/UTB/2023/392 dated 04.08.2023 by Mr.